Background: Colorectal cancer (CRC) is the third most prevalent form of cancer worldwide and the second most diagnosed form of cancer in Canada. G proteincoupled receptors (GPCRs) are suspected to play a key role in CRC tumorigenesis. The tumorigenic process is divided into three steps: initiation, promotion and tumor progression. Formation of metastases is based on cell cancer capacity to migrate during early stages of tumorigenesis. Identification of new targets involved in CRC development is a major challenge to improve diagnostic and treatment of this form of cancer. Aims: Past research has identified the GPCR P2Y 6 as such innovative target. In fact, P2Y 6 activities were involved in different stages of colorectal tumorigenesis. We demonstrated that P2y 6 -/-mice significantly develop fewer tumors than control mice in a CRC mouse model. Other studies confirmed that P2Y 6 played a role in the epithelial to mesenchymal transition (EMT) and accelerated migration of breast cancer MDA-MB-468 cells. Surprisingly, there is sparse information about the potential influence of P2Y 6 action in cancer cell migration and on the mechanism involved in this process. That's why, in this study, we wanted to characterise P2Y 6 signalling in cell migration. Methods: We studied effects of this receptor on cell migration by using wound healing assays and we showed migrating structures by immunofluorescence assays and western blots. Results: In this work, we showed that P2Y 6 activation lead to cell migration using wound healing assays. This migratory stimulating effect was the result of the formation of filopodia and focal adhesions, known as migrating structures, and the cofilin phosphorylation. The formation of filopodia was associated to the P2Y 6 dependent modulation of CDC42 protein expression whereas cofilin phosphorylation was correlated to the Rho/ROCK pathway. Conclusions: These results are thus supporting the idea that the P2Y 6 receptor is involved in cell migration and it could be a target for the treatment of CRC.
